IPCA Laboratories Limited — Board Meeting, 28-03-2025: Outcome of Board Meeting

The Board of Directors and Audit Committee have approved significant strategic decisions. The company will sell its formulations manufacturing facility in Tarapur for Rs. 36.90 crores to V. S. International Pvt. Ltd. This move is aimed at reducing operational costs, with the assurance that current production can be shifted to other facilities without impact on business operations.

Additionally, the company will acquire 100% share capital of Unichem Laboratories Ltd., Ireland, from Unichem Laboratories Ltd., India, for Rs. 4 crores in cash. This acquisition is intended to establish a front-end presence in the European market for pharmaceutical registrations and distribution. Completion of both transactions is expected by June 2025.